National Specialist Ophthalmic Pathology Service, Department of Histopathology, Royal Hallamshire Hospital, Sheffield, United Kingdom.
Department of Pathology, Wills Eye Hospital, Sidney Kimmel Medical College of Thomas Jefferson University, Philadelphia, Pennsylvania.
Ophthalmology. 2021 May;128(5):765-778. doi: 10.1016/j.ophtha.2020.09.033. Epub 2020 Sep 29.
To evaluate the distribution of the PAX8 transcription factor protein in ocular tissues and to investigate if immunohistochemical stains for this biomarker are useful in the diagnosis of intraocular tumors.
Observational case series.
Excision and cytologic analysis specimens of 6 ciliary body epithelial neoplasms, 2 iris epithelial neoplasms, 3 retinal pigment epithelial neoplasms, 3 intraocular medulloepitheliomas, 15 uveal melanomas, and 5 uveal melanocytomas.
Hematoxylin-eosin and PAX8 immunohistochemical stains were performed on all specimens. In appropriate cases, bleached preparations and other immunohistochemical stains, including AE1/AE3 cytokeratin, Lin28A, and CD45, were performed.
Distribution of PAX8 expression in normal and neoplastic tissue.
Strong nuclear PAX8 expression was observed in the normal corneal epithelium, iris sphincter pupillae muscle, iris pigment epithelium and dilator muscle complex, nonpigmented and pigmented epithelia of the ciliary body, lens epithelium, and a subset of retinal neurons. The normal retinal pigment epithelium and uveal melanocytes did not stain for PAX8. The ciliary body epithelial and neuroepithelial tumors (adenoma, adenocarcinoma, and medulloepithelioma) showed uniform strong nuclear PAX8 immunoreactivity. All melanocytic tumors (iris melanoma, ciliary-choroidal melanoma, and melanocytoma) and retinal pigment epithelial neoplasms showed negative results for PAX8. A subset of tumor-associated lymphocytes, most prominent in uveal melanoma, showed positive results for PAX8. The uniformity of the PAX8 staining was superior to the variable cytokeratin staining in the ciliary epithelial neoplasms and the variable Lin28A staining in malignant medulloepithelioma. The veracity of PAX8 staining was equally as robust on cytologic analysis and open-flap biopsy specimens of ciliary epithelial and iris epithelial neoplasms, melanocytoma, and melanoma.
PAX8 has proven to be a very useful diagnostic marker in a select group of adult intraocular tumors, and we highly recommend its inclusion in diagnostic antibody panels of morphologically challenging intraocular neoplasms.
评估 PAX8 转录因子蛋白在眼部组织中的分布,并探讨该生物标志物的免疫组织化学染色在眼内肿瘤诊断中的应用价值。
观察性病例系列研究。
睫状体上皮肿瘤 6 例、虹膜上皮肿瘤 2 例、视网膜色素上皮肿瘤 3 例、眼内髓上皮瘤 3 例、脉络膜黑色素瘤 15 例和脉络膜黑色素细胞瘤 5 例的切除和细胞学分析标本。
对所有标本进行苏木精-伊红和 PAX8 免疫组织化学染色。在适当的情况下,进行漂白处理和其他免疫组织化学染色,包括 AE1/AE3 细胞角蛋白、Lin28A 和 CD45。
PAX8 表达在正常和肿瘤组织中的分布。
正常角膜上皮、虹膜瞳孔括约肌、虹膜色素上皮和扩瞳肌复合体、睫状体无色素和色素上皮、晶状体上皮和部分视网膜神经元均观察到强烈的核 PAX8 表达。正常视网膜色素上皮和葡萄膜黑素细胞不染色 PAX8。睫状体上皮和神经上皮肿瘤(腺瘤、腺癌和髓上皮瘤)显示均匀强核 PAX8 免疫反应性。所有黑色素细胞瘤(虹膜黑色素瘤、睫状体脉络膜黑色素瘤和黑色素细胞瘤)和视网膜色素上皮肿瘤均对 PAX8 呈阴性反应。肿瘤相关淋巴细胞的一部分,在脉络膜黑色素瘤中最为明显,显示 PAX8 阳性。PAX8 染色的均匀性优于睫状体上皮肿瘤中可变的细胞角蛋白染色和恶性髓上皮瘤中可变的 Lin28A 染色。PAX8 染色在细胞学分析和睫状体上皮和虹膜上皮肿瘤、黑色素细胞瘤和黑色素瘤的开放式活检标本中的准确性同样强大。
PAX8 已被证明是一组成人眼内肿瘤非常有用的诊断标志物,我们强烈建议将其纳入形态学具有挑战性的眼内肿瘤诊断抗体组合中。